Cargando…
Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD)...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554658/ https://www.ncbi.nlm.nih.gov/pubmed/36245510 http://dx.doi.org/10.3389/fnut.2022.987400 |
_version_ | 1784806749109223424 |
---|---|
author | Zhou, Jingbo Xu, Gaoshun Li, Xinyue Tu, Huayu Li, Haoyu Chang, Hong Chen, Jie Yu, Renqiang Qi, Ce Sun, Jin |
author_facet | Zhou, Jingbo Xu, Gaoshun Li, Xinyue Tu, Huayu Li, Haoyu Chang, Hong Chen, Jie Yu, Renqiang Qi, Ce Sun, Jin |
author_sort | Zhou, Jingbo |
collection | PubMed |
description | OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD) in mice. METHODS: In intervention mode I, FN041 was supplemented to dams during the late trimester and lactation and pups after weaning; in intervention mode II, FN041 was supplemented after pups were weaned. AD was induced in pups with MC903 plus ovalbumin on the ear after weaning. RESULTS: The effect of intervention mode I in preventing AD was significantly better than that of intervention mode II. Compared with the model group, the inflammatory response of the pup’s ears, the proportion of spleen regulatory T cells and the plasma IgE were significantly decreased in mice in intervention mode I. Furthermore, the intestinal mucosal barrier was enhanced, and the Shannon index of the ileal microbiota was significantly increased. The microbiota structure deviated from the AD controls and shifted toward the healthy controls according to the PCoA of unweighted UniFrac. The relative abundances of Limosilactobacillus, Faecalibacterium, Bifidobacterium, and Akkermansia in the ileum were significantly increased compared to the AD group. Based on RNA-seq analysis of pups’ Peyer’s patches (PPs), FN041 inhibits autoimmune pathways such as asthma and systemic lupus erythematosus and activates retinol metabolism and PPAR signaling pathways to reduce inflammatory responses. Intervention mode II also significantly reduced AD severity score, but the reduction was approximately 67% of that of intervention mode I. This may be related to its ineffective remodeling of the ileal microbiota. CONCLUSION: Prenatal and postnatal administration of FN041 is an effective way to prevent AD in offspring, and its mechanism is related to remodeling of ileal microbiota and PPs immune response. |
format | Online Article Text |
id | pubmed-9554658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95546582022-10-13 Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission Zhou, Jingbo Xu, Gaoshun Li, Xinyue Tu, Huayu Li, Haoyu Chang, Hong Chen, Jie Yu, Renqiang Qi, Ce Sun, Jin Front Nutr Nutrition OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD) in mice. METHODS: In intervention mode I, FN041 was supplemented to dams during the late trimester and lactation and pups after weaning; in intervention mode II, FN041 was supplemented after pups were weaned. AD was induced in pups with MC903 plus ovalbumin on the ear after weaning. RESULTS: The effect of intervention mode I in preventing AD was significantly better than that of intervention mode II. Compared with the model group, the inflammatory response of the pup’s ears, the proportion of spleen regulatory T cells and the plasma IgE were significantly decreased in mice in intervention mode I. Furthermore, the intestinal mucosal barrier was enhanced, and the Shannon index of the ileal microbiota was significantly increased. The microbiota structure deviated from the AD controls and shifted toward the healthy controls according to the PCoA of unweighted UniFrac. The relative abundances of Limosilactobacillus, Faecalibacterium, Bifidobacterium, and Akkermansia in the ileum were significantly increased compared to the AD group. Based on RNA-seq analysis of pups’ Peyer’s patches (PPs), FN041 inhibits autoimmune pathways such as asthma and systemic lupus erythematosus and activates retinol metabolism and PPAR signaling pathways to reduce inflammatory responses. Intervention mode II also significantly reduced AD severity score, but the reduction was approximately 67% of that of intervention mode I. This may be related to its ineffective remodeling of the ileal microbiota. CONCLUSION: Prenatal and postnatal administration of FN041 is an effective way to prevent AD in offspring, and its mechanism is related to remodeling of ileal microbiota and PPs immune response. Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9554658/ /pubmed/36245510 http://dx.doi.org/10.3389/fnut.2022.987400 Text en Copyright © 2022 Zhou, Xu, Li, Tu, Li, Chang, Chen, Yu, Qi and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Zhou, Jingbo Xu, Gaoshun Li, Xinyue Tu, Huayu Li, Haoyu Chang, Hong Chen, Jie Yu, Renqiang Qi, Ce Sun, Jin Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title | Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title_full | Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title_fullStr | Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title_full_unstemmed | Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title_short | Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission |
title_sort | limosilactobacillus reuteri fn041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in peyer’s patches after vertical transmission |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554658/ https://www.ncbi.nlm.nih.gov/pubmed/36245510 http://dx.doi.org/10.3389/fnut.2022.987400 |
work_keys_str_mv | AT zhoujingbo limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT xugaoshun limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT lixinyue limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT tuhuayu limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT lihaoyu limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT changhong limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT chenjie limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT yurenqiang limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT qice limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission AT sunjin limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission |